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Background: Little evidence exists regarding the optimal concentration of oxygen to use in the treatment of term
neonates with spontaneous pneumothorax (SP). The practice of using high oxygen concentrations to promote
“nitrogen washout” still exists at many centers. The aim of this study was to identify the time to clinical resolution
of SP in term neonates treated with high oxygen concentrations (HO: FiO2 ≥ 60%), moderate oxygen
concentrations (MO: FiO2 < 60%) or room air (RA: FiO2 = 21%).
Methods: A population based cohort study that included all term neonates with radiologically confirmed
spontaneous pneumothorax admitted to all neonatal intensive care units in Calgary, Alberta, Canada, within
72 hours of birth between 2006 and 2010. Newborns with congenital and chromosomal anomalies, meconium
aspiration, respiratory distress syndrome, and transient tachypnea of newborn, pneumonia, tension pneumothorax
requiring thoracocentesis or chest tube drainage or mechanical ventilation before the diagnosis of pneumothorax
were excluded. The primary outcome was time to clinical resolution (hours) of SP. A Cox proportional hazards
model was developed to assess differences in time to resolution of SP between treatment groups.
Results: Neonates were classified into three groups based on the treatment received: HO (n = 27), MO (n = 35) and
RA (n = 30). There was no significant difference in time to resolution of SP between the three groups, median
(range 25th-75th percentile) for HO = 12 hr (8–27), MO = 12 hr (5–24) and RA = 11 hr (4–24) (p = 0.50). A significant
difference in time to resolution of SP was also not observed after adjusting for inhaled oxygen concentration [MO
(a HR = 1.13, 95% CI 0.54-2.37); RA (a HR = 1.19, 95% CI 0.69-2.05)], gender (a HR = 0.87, 95% CI 0.53-1.43) and ACoRN
respiratory score (a HR = 0.7, 95% CI 0.41-1.34).
Conclusions: Supplemental oxygen use or nitrogen washout was not associated with faster resolution of SP.
Infants treated with room air remained stable and did not require supplemental oxygen at any point of their
admission.
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Pneumothorax is one of the most common air leak syn-
dromes that occurs in the newborn period [1]. It is classi-
fied into primary pneumothorax (without any obvious
lung diseases) and secondary pneumothorax (due to
underlying lung pathology, or associated with precipitating
factors such as transient tachypnea of newborn, meco-
nium aspiration, continuous positive pressure ventilation
(CPAP), mechanical ventilation, pneumonia, respiratory
distress syndrome or post surfactant treatment) [1-5].
Spontaneous pneumothorax (SP) is a form of primary
pneumothorax in neonates. It usually occurs in the ab-
sence of inciting risk factors at birth [1]. The mechan-
ism is related to maladaptive transition after birth. The
presence of persistently high or unequal transpulmon-
ary inflating pressure in the alveoli during the transition
period results in rupture of alveoli into the pleural space
and produces a spontaneous pneumothorax [6,7]. The
incidence of radiologic SP is 1% to 2% and symptomatic
SP is 0.05% to 1% in all live births [1,4,8]. Pneumothorax
increases morbidity, prolongs hospital stay, causes parental
anxiety and, in some cases, can also result in death [1,8,9].
The adult literature suggests that inhaling higher con-
centrations of oxygen between 60% to 100% (nitrogen
washout) compared to room air improves the rate of
resolution of symptomatic SP [10-12]. The theory of ni-
trogen washout proposes that the inhalation of 100%
oxygen reduces the partial pressure of nitrogen in the al-
veolus compared to the pleural space. This gradient dif-
ference causes the nitrogen to diffuse from the pleural
space into the alveoli, resulting in resorption of air from
the pleural space into the alveoli and faster resolution of
the pneumothorax [6,10]. The treatment of SP in term
neonates is based on theoretical and historical hypotheses,
which favor the use of higher oxygen concentrations/
nitrogen washout for rapid resolution of SP [13,14].
However, there is minimal published evidence available
for the optimal inspired oxygen concentration require-
ment to treat clinically significant SP in term neonates
[15-17]. Empirically, SP is treated with variable concen-
trations of oxygen [17].
Treatment of SP with higher oxygen concentrations
may lead to hyperoxic injury in neonates [18]. Hyperoxia
produces free oxygen radicals and enhances cellular apop-
tosis. It can alter the genetic expression of the cell and
may be a cause of potential childhood cancers [19]. Unre-
stricted oxygen use poses a financial burden to the health
care system due to prolonged neonatal intensive care unit
(NICU) admission [15]; this burden is more profound in
resource poor countries [16].
To the best of our knowledge, in the term neonatal popu-
lation, no standardized management guidelines or concrete
evidence are available in the literature that show an ad-
vantage or disadvantage of using higher concentrationsof oxygen for resolution of spontaneous pneumothorax.
In our NICU there are three practice patterns. Some
neonatologists treat SP with nitrogen washout (60 to
100% inspired O2 concentration); some titrate the O2
concentration targeting a pulse oximeter O2 saturation
(SpO2) ≥ 95%; and some treat with room air alone. We
hypothesized that term neonates who inhaled higher
oxygen concentrations/nitrogen washout would have a
quicker resolution of spontaneous pneumothorax as com-
pared to infants treated with room air or lower oxygen
concentrations. The aim of this study was to identify the
time to clinical resolution of spontaneous pneumothorax
in term neonates treated with high fraction of inspired
oxygen (FiO2)/nitrogen washout (HO: FiO2 ≥ 60%), moderate
oxygen (MO: FiO2 < 60%) or room air (RA: FiO2 = 21%).
Methods
Data source and settings
This was a population based cohort study of spontaneous
pneumothorax in term neonates in Calgary, Alberta,
Canada. We reviewed the medical records (both electronic
data and patients’ charts) of all term infants admitted with
a diagnosis of pneumothorax to all NICUs in Calgary be-
tween 1st January 2006 to 31st December 2010. The list of
patients was retrieved from the NICU database and the
medical records departments by identifying infants with
an ICD-9-CM (512 and 512.81) and an ICD-10-CM (J93.1
and P25.1) code for pneumothorax. Ethics approval was
obtained from the Conjoint Health Research Ethics Board
at the University of Calgary.
All term newborns (gestational age ≥37 weeks) admitted
to the NICU from birth to 72 hours of life with signs of re-
spiratory distress and a diagnosis of spontaneous pneumo-
thorax confirmed by chest X-ray (CXR), were included in
the study. Newborns with congenital/chromosomal anom-
alies, history of meconium stained liquor/meconium aspir-
ation, respiratory distress syndrome, transient tachypnea
of newborn, pneumonia, tension pneumothorax requiring
thoracocentesis or chest tube drainage, those who received
positive pressure ventilation (PPV) or mechanical ventila-
tion (MV) before the diagnosis of spontaneous pneumo-
thorax were excluded.
Based on initial fraction of inspired oxygen concentra-
tion used at admission for the treatment of SP, neonates
were divided into three groups: high fraction of inspired
oxygen (FiO2)/nitrogen washout (HO: FiO2 ≥ 60%), mod-
erate oxygen (MO: FiO2 < 60%) or room air (RA: FiO2 =
21%). The decision to treat a patient with room air, high
or moderate oxygen concentration was based on individ-
ual attending neonatologist preference.
The initial concentration of oxygen used for treatment
of spontaneous pneumothorax was the primary exposure
variable. Duration of oxygen therapy was calculated from
the initiation of oxygen therapy until clinical resolution
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of tension pneumothorax within 72 hours of diagnosis
and treatment of SP). Data on maximum O2 concentra-
tion inspired during the treatment period was based on
the highest recorded dose documented in the chart. The
method of oxygen delivery at the time of admission was
either via oxyhood, or nasal cannula. The concentration
of inspired oxygen via oxyhood was analyzed through an
oxygen analyzer. The concentration of inspired oxygen
through nasal prongs was calculated according to the
“STOP- ROP effective FiO2 conversion table” [20], a
modified equation described by Benaron and Benitz [21].
The severity of respiratory distress was classified accor-
ding to the validated “Acute care of at-risk newborn
(ACoRN)” respiratory score [22-24]. The estimation of
pneumothorax size was abstracted from the radiologist
report; radiologists were blinded to the treatment group.
There was no validated method available to measure the
size of pneumothorax on CXR in neonates so an estima-
tion was made according to adult guidelines as mentioned
in the British Thoracic Society (BTS) guidelines [10], and
from the neonatal literature [8,25-27].
Clinical resolution of pneumothorax was defined as
cessation of respiratory distress and discontinuation of
oxygen treatment with maintenance of SpO2 ≥ 95%. Nitro-
gen washout was defined in our NICU as the use of 60 to
100% of inspired O2 continuously for at least 6 hours.
Time to clinical resolution of spontaneous pneumo-
thorax, measured in hours was the primary outcome vari-
able. Neonates were followed from admission until clinical
resolution of pneumothorax as documented in the patient
chart. The secondary outcome variables were length of
hospital stay for the treatment of pneumothorax and treat-
ment failure (development of tension pneumothorax
within 72 hours of diagnosis and treatment of SP). Ten-
sion pneumothorax was characterized by rapid instability
of vital signs and shifting of the mediastinum on CXR, re-
quiring thoracocentesis, chest tube insertion or mechan-
ical ventilation [25].Statistical analysis
Descriptive statistics were used to describe the study popu-
lation. Chi-square tests, analysis of variance (ANOVA)
and Kruskal-Wallis tests were used to assess differences
in categorical and continuous variables stratified by the
concentration of oxygen received. A Cox proportional
hazards model was used to assess differences in time to
clinical resolution of SP. A crude model and a model ad-
justed for infant gender and ACoRN respiratory score
were derived. An adjusted hazard ratio (aHR) >1 would
indicate a benefit of oxygen treatment. P value < 0.05 was
taken as significant. All analyses were conducted in Stata
SE version 11.Results
Two hundred and eighty nine medical charts of neonates,
admitted between 1st January, 2006 to 31st December,
2010 with a diagnosis of pneumothorax were reviewed
(Figure 1). Ninety two neonates had spontaneous pneumo-
thorax and were included in the study. Based on a total
number of 80,819 births during the study period, the inci-
dence of pneumothorax was 0.35% and that of SP was
0.11% at our centre.
Eligible neonates were further classified into 3 groups,
according to the inhaled oxygen concentration at the ini-
tiation of treatment; 27 in the HO group (FiO2 ≥60%),
35 in the MO group (FiO2 < 60%) and 30 in the RA
group (FiO2 21%). All neonates received oxygen via an
oxyhood in the HO group. In the MO group, 30 neo-
nates received oxygen via an oxyhood and 5 neonates re-
ceived blended oxygen through nasal prongs. There was
no cross over in the treatment groups. All the patients
in the HO, MO and RA groups remained in their desig-
nated groups. The maternal baseline characteristics were
similar in all three groups (Table 1). Neonatal baseline
characteristics in terms of gestational age, birth weight,
resuscitation requirement at birth, Apgar scores and ad-
mission age were comparable. Although male infants
were more likely to be treated with RA than MO or HO
(p = 0.01), this observation could be due to chance and
be a reflection of the small sample size (Table 1). This
difference was adjusted for in the model (a HR = 0.87,
95% CI 0.53-1.43, p = 0.59).
The median (range 25%-75%) time to clinical reso-
lution of SP was 11 hours (4–24) for infants treated with
RA, 12 hours (5–24) for infants treated with MO and
12 hours (8–27) for infants treated with HO (p = 0.5).
Both crude (MO HR = 0.84, 95% CI 0.50-1.43; RA HR =
1.06, 95% CI: 0.64-1.76) and adjusted (for infant sex and
ACoRN respiratory score) [MO (a HR = 1.13, 95% CI
0.54-2.37, p = 0.75); RA (a HR = 1.19, 95% CI 0.69-2.05,
p = 0.52)] models did not indicate a statistically signifi-
cant difference in the time to resolution of spontaneous
pneumothorax based on treatment group, indicating that
treatment with different concentrations of inhaled oxygen
do not significantly alter the hazard function and influence
time to resolution of SP. This is supported by the overlap-
ping survival curves between the 3 treatment groups
found in Figure 2. All groups experienced a comparable
resolution time of approximately 12 hours for the majority
of infants, with occasional neonates requiring treatment
for approximately 24 hours. Exceptional neonates requir-
ing prolonged treatment due to underlying disease were
observed in all treatment groups. Two neonates in the RA
group had prolonged time to resolution of pneumothorax
(130–160 hours), one had pneumothorax associated with
sepsis and the other had pneumothorax and subcutaneous
emphysema. In the MO (2 neonates) and HO (4 neonates)
Total no. of infants diagnosed with pneumothorax
N = 289
Total excluded, N =197
(more than one cause included)
Meconium stained liquor (n = 122)
PPV/Mechanical ventilation (n = 98)
Thoracocentesis/chest tube (n = 6)
CHD/Syndrome (n = 6)
Birth asphyxia (n = 5)
Pneumonia/ TTN (n = 5)








Figure 1 Flow diagram showing population profile. RA = room air, MO = moderate oxygen concentration, HO = high oxygen concentration,
PPV = positive pressure ventilation, CHD = congenital heart disease, TTN = transient tachypnea of newborn.
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associated possibly with delayed pulmonary adaptation to
the extra uterine life. We speculate those neonates might
have underlying labile pulmonary hypertension. Those ne-
onates did not require mechanical ventilator support, in-
haled nitric oxide and their blood gases were normal.
To maintain oxygen saturations more than 95%, the
inspired oxygen concentration at initiation of treatmentTable 1 Baseline maternal and neonatal characteristics
Characteristics RA
Maternal
Maternal age (yrs), mean (SD) 29.4
Antenatal corticosteroids, n (%) 0 (0
Chorioamnionitis, n (%) 3 (1
Cesarean section, n (%) 8 (2
Neonatal
Male, n (%) 28 (
GA, wks, mean (SD) 39 (
BW, g, mean (SD) 332
Resuscitation at birth, n (%) (free flow oxygen only) 4 (1
Apgar score at 5 min, median (range 25th -75th percentile) 9 (8
Age of admission, hours, median (range 25th -75th percentile) 0.3
RA = room air, MO = moderate oxygen concentration, HO = high oxygen concentrawas also higher in the HO group. Neonates in the HO
group were sicker, had higher ACoRN scores (Table 2)
and their oxygen saturations were also low at the time of
admission to the NICU (Table 1). However, the adjusted
hazard ratio after adjustment with ACoRN score (a HR =
0.74, 95% CI 0.41-1.34, p = 0.32) did not show significant
difference in the time to clinical resolution of SP (Figure 2).
Six neonates in total (MO (n = 4/35) and HO (n = 2/27))(n = 30) MO (n = 35) HO (n = 27) P
(5.4) 28.6 (5.9) 30.0 (6.2) 0.64
.0) 2 (5.7) 0 (0.0) 0.19
0.0) 2 (5.7) 2 (7.4) 0.81
6.7) 16 (45.7) 13 (48.1) 0.18
93.3) 24 (68.6) 16 (59.3) 0.01
1.2) 39 (1.2) 39 (1.2) 0.90
8.5 (471.3) 3480.9 (487.8) 3405.0 (435.7) 0.43
3.3) 8 (22.9) 5 (18.5) 0.62
–9) 9 (9–9) 9 (8–9) 0.41
(0.2-1.0) 1 (0.1-20.0) 0.5 (0.2-3.0) 0.19
















































0 50 100 150 200
Time to Resolution of Pneumothorax (Hours)
Room Air (RA) >=60% Oxygen (HO)
<60% Oxygen (MO)
Figure 2 Survival curve of time to clinical resolution of pneumothorax by concentration of oxygen received (adjusted model).
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centesis, chest tube placement or mechanical ventilator
support), and they were excluded from the analysis. They
might have more serious underlying disease, though the
p-value was not significant (Table 2). While in RA group,Table 2 Neonatal outcomes
Characteristics
Median (range 25th-75th percentile)
SpO2 (%) at admission
Concentration of oxygen (%) inspired at initiation of treatment
Maximum oxygen concentration (%) inspired during the treatment period
Total duration of supplemental oxygen therapy, hours
Respiratory rate at admission
ACoRN score at admission
ACoRN score according to severity
<5
≥5
Length of hospital stay, hours
Number (%)









SpO2 = saturation of peripheral oxygen.
aWilcoxon Rank Sum Test was used to asse
and MO groups.none of the neonate developed tension pneumothorax or
treatment failure. Two neonates from MO and HO group
had chest tube drains followed by thoracocentesis, while
the other two neonates in MO group only required thora-
cocentesis. Ventilator support was required by one neonateRA (n = 30) MO (n = 35) HO (n = 27) P
96.5 (94–99) 89 (81–94) 88 (83–92) < 0.001
21 (21–21) 35 (29–40) 85 (65–100) < 0.001a
21 (21–21) 40 (30–50) 85 (65–100) < 0.001a
0 (0–0) 10 (3–23) 12 (8–27) 0.19a
63 (52–75) 65 (54–74) 72 (64–80) 0.13
3 (2–4) 4 (3–6) 6 (5–7) < 0.001
< 0.001
26 (86.7) 23 (65.7) 2 (7.4)
4 (13.3) 12 (34.3) 25 (92.6)
47.3 (23.5-64.0) 47.3 (24.0-95.3) 47.5 (27.3-71.9) 0.54
0.88
11 (36.7) 17 (48.6) 13 (48.1)
10 (33.3) 10 (28.6) 7 (25.9)
9 (30.0) 8 (22.9) 7 (25.9)
0.18
21 (70.0) 25 (71.4) 15 (55.6)
9 (30.0) 6 (17.1) 10 (37.0)
0 (0.0) 4 (11.4) 2 (7.4)
0 (0.0) 4 (11.4) 2 (7.4) 0.17a
ss statistical differences. P-values only represent a comparison between the HO
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was that none of the neonates in the RA group required
supplemental oxygen treatment at any time of their hos-
pital stay. The length of NICU stay was similar in all three
groups (Table 2). There were no deaths observed in any
group.
Discussion
Symptomatic spontaneous pneumothorax is one of the
main reasons for admission of term newborn infants to
the NICU. As most cases of SP present with mild re-
spiratory distress, the management of SP with or without
supplemental oxygen is invariably different between phy-
sicians [16,17]. No consensus exists regarding the treat-
ment of symptomatic spontaneous pneumothorax in
stable term neonates. Questions such as whether or not
spontaneous pneumothorax in term neonates should be
treated with supplemental oxygen and whether higher
oxygen concentrations, based on the historical hypothesis
of nitrogen washout is helpful in the speedy resolution of
spontaneous pneumothorax are still unanswered. To the
best of our knowledge, this is the first study which focuses
on the time to clinical resolution of SP in neonates treated
with room air (21% FiO2) and with different supplemental
oxygen concentrations.
No difference was observed in the time to clinical reso-
lution of SP between infants treated with room air or dif-
ferent concentrations of oxygen in our study. Even after
adjustment for respiratory morbidity and gender, neonates
in the HO group (≥60% FiO2) did not show a rapid reso-
lution of the SP.
There are several studies on neonatal pneumothorax
and its risk factors; however there is a scarcity of studies
on the effect of oxygen dose dependant resolution of SP
in the neonatal population. An older study by Yu et al.
in 1975 noted speedy resolution of spontaneous pneumo-
thorax (within 48 hours) in neonates treated with higher
oxygen concentrations [14]. The drawback of this study is
that it included both term and preterm neonates with all
types of pneumothorax; and there was no comparison
done with respect to different oxygen concentrations on
the resolution rate of SP. A more recent study examined
the time to resolution of spontaneous pneumothorax with
100% O2 inhalation in 45 term and near term neonates
(>35 weeks gestation age) [17]. In this retrospective study,
Clark et al. compared neonates receiving inhaled 100% O2
(nitrogen washout group) (n = 26) and neonates receiving
different concentrations of O2 targeting the SpO2 between
92 to 95% (n = 19), conventional therapy group [17]. Their
findings corroborate our results. They did not find a sig-
nificant difference in the mean time to resolution of tach-
ypnea (20 hours, standard deviation (SD) ± 26 vs. 37 hours,
SD ± 27, p = 0.181), mean length of hospital stay (3.53 days,
SD ± 1.68 vs. 4.35 days, SD ±1.96, p = 0.168) and meantime to first oral feed between the conventional therapy
and nitrogen washout groups [17]. Our study differs in that
we studied the impact of different O2 concentrations as
well as the effect of room air (21% FiO2) on the resolution
of SP. We observed that the time to resolution of SP was
not significantly longer in neonates who were just in room
air (21% FiO2) vs. neonates receiving different O2 concen-
trations higher than the room air. An interesting finding
was that neonates in room air never required sup-
plemental oxygen, or experienced treatment failure
(pneumothorax, need for thoracocentesis, chest tube in-
sertion or mechanical ventilation) at any time during
their hospitalization. This could mean that room air
(21% FiO2) may be as effective as any higher inhaled O2
concentrations for resolution of SP. Future trials will
possibly find the room air as the optimal O2 concentration
requirement for resolution of symptomatic pneumothorax
and prevention of O2 toxicity.
All other studies which focused on the resolution rate of
spontaneous pneumothorax in association with inhaled
O2 concentration were conducted on animal subjects. A
randomized clinical trial on 23 rabbits, in whom unilateral
pneumothorax was induced, Ronald et al. observed [28]
that the resolution rate of pneumothorax was shorter
(36 hours) in the group that received a higher concentra-
tion of oxygen (FiO2 ≥ 60%), compared to the group that
was treated with room air (48 hours) [28]. In two other
studies on rabbits by England [29] and Zierold [30], the
rate of resolution was dependent on the concentration of
oxygen. The higher the concentration of inspired oxygen,
the faster the resolution of pneumothorax. Two studies
were identified in adults for the treatment of pneumo-
thorax with oxygen inhalation [11,31]. A prospective study
in adults by Chadha [31] observed an increased rate of
resolution of pneumothorax when treated with higher
concentrations of inspired oxygen. The other study in
22 adult patients, divided into two groups (1-treated
with room air and 2- intermittently treated with room
air and oxygen from 9–36 hours, at 16 L/min flow) also
showed a positive correlation on the rate of absorption
of pneumothorax with oxygen treatment [11]. The reso-
lution rate of pneumothorax was 4.8 cm2/day with room
air in both groups and increased to 17.9 cm2/day with
oxygen treatment in the second group [11]. No side ef-
fects of oxygen therapy were observed in this small
study.
This retrospective study has few limitations due to the
selection and information bias (detection bias). It was
difficult to control bias and confounders due to the ab-
sence of randomization and blinding in this study. We
had no control over some variables, therefore for homo-
geneity and as a reference we recorded these variables
when these were observed at the time of admission. Al-
though the use of higher oxygen concentration in sick
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the admission, there was no targeted SpO2 goal observed
to wean the inspired O2 concentrations despite of the
decrement in respiratory severity scores. The oxygen
concentration used at admission and the duration of
oxygen treatment was widely variable and depended on
the discretion of the admitting physician. The prescrip-
tion for continuous “nitrogen washout” for minimum of
6 hours was clearly documented in the nursing notes,
however there was no indication mentioned for titration
of O2 concentration on achievement of SpO2 > 95%. This
reflects the cultural and historical beliefs of physicians
and nurses with regard to nitrogen washout treatment.
We observed a decreasing trend in the use of oxygen
treatment over time; while this did not achieve statistical
significance (p = 0.822), this may be related to the small
sample size when stratified by oxygen concentration and
year. This decreasing trend may be the influence of
emerging new literature on oxygen treatment as a drug
and its pros and cons, especially toxicity of oxygen free
radicals.
We did not have a CXR on every patient at the time of
discharge from the NICU to determine the radiologic
resolution of pneumothorax. Therefore we decided to
record the time to clinical resolution of SP from clinical
notes in the patient charts. According to the BTS guide-
lines [10], chest computed tomography (CT) scan is the
best modality for accurate estimation of the size of
pneumothorax. However, the size of pneumothorax does
not always correlate well with the severity and resolution
of symptoms associated with the pneumothorax [10].
Therefore, the management should be tailored according
to the clinical severity [10]. The same clinical judgment
for pneumothorax treatment is also applied to neonatal
management. In newborns, there is no validated method
available for correct estimation of size of pneumothorax
on CXR. Portable CT scans are very costly, not available
for sick babies and carry the risk of radiation. Due to the
above mentioned reasons and inconsistency of the radio-
logical reporting for the size of pneumothorax in neo-
nates, the significance of size with the time to resolution
of pneumothorax is not very reliable. Therefore, for the
purpose of our study, we determined that the best option
for calculating the time to resolution of pneumothorax
was the clinical resolution of signs. The results of our
study are applicable in neonates at other centres.
Conclusions
This study has been the first to determine the time to
clinical resolution of spontaneous pneumothorax in term
neonates treated with room air and different concentra-
tions of inhaled oxygen. We found that supplemental oxy-
gen use was not associated with faster resolution of SP in
HO and MO groups. Neonates who were treated withroom air rather than supplemental oxygen did not have
longer recovery times. Oxygen treatment for pneumo-
thorax should be viewed as a prescribed drug, with docu-
mentation for its indication, target saturation and titration
goals. Future prospective trials for the treatment of symp-
tomatic spontaneous pneumothorax using 100% inspired
oxygen concentration vs. room air in sick neonates with
targeted SpO2 goal, will be beneficial in developing an ac-
ceptable treatment guideline for term neonates.
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